Register
|
Sign in
Home
Colon & Rectum
Disease prevention
Inflammatory bowel disease
Liver/pancreas
Oesophagus
Small Intestine
Stomach
Go
Cetuximab considered by PBAC
17 March 2010
Cetuximab (Erbitux) is being considered for PBS listing by the Pharmaceutical Benefits Advisory Committee for the treatment of metastatic bowel cancer....
Want to read complete article? Please
Sign in
or
Register
.
Most viewed articles this week
Duodenal morphometry more sensitive than Marsh grade
(01/09/2010)
GESA revokes commitment to host APDW 2011
(01/09/2010)
Australian assay determines hep C treatment response
(01/09/2010)
FOBT advised between colonoscopies
(18/08/2010)
Australian IBD rates high
(01/09/2010)
Recent comments
Kevin Hourigan
said "
GESA seems to be working hard and well with Infection Control guidelines in endoscopy units.It..."
Prof Thomas J Borody
said "
Dear Editor, I would like to correct a statement made by Tony James on his article..."
Related sites
6minutes
Australian Doctor
Cardiology Update
Endocrinology Update
Neurology Update
Oncology Update
Pharmacy News
Psychiatry Update
Rheumatology Update